Skip to content

Analysis of the efficacy and prognosis of CT-guided radioactive iodine 125 seed implantation in the treatment of thoracic malignant tumors

Analysis of the efficacy and prognosis of CT-guided radioactive iodine 125 seed implantation in the treatment of thoracic malignant tumors

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400081993
Enrollment
Unknown
Registered
2024-03-18
Start date
2024-04-01
Completion date
Unknown
Last updated
2024-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant tumors of the thorax

Interventions

Study group:None

Sponsors

The Third Clinical School of Xinjiang Medical University (Affiliated Tumor Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Complete clinical data; 2.Article implantation plan and verification follow-up data were complete; 3.Reexamination and imaging examination = 1 time within 6 months after operation; 4.Expected survival = 6 months.

Exclusion criteria

Exclusion criteria: Patients with any of the following items cannot be enrolled in this study : 1.Incomplete clinical data; 2.The follow-up data of particle implantation plan and verification were incomplete; 3.No imaging review and follow-up were performed within 6 months after operation; 4.The expected survival time was less than 6 months.

Design outcomes

Primary

MeasureTime frame
Objective response rate;Disease control rate;

Secondary

MeasureTime frame
Progression-free survival;Overall survival;

Countries

China

Contacts

Public ContactZhu Tao

The Third Clinical School of Xinjiang Medical University (Affiliated Tumor Hospital)

1272105562@qq.com+86 133 8358 1494

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026